Dr Helen Dearden

Dr Helen Dearden is an experienced Consultant Medical Oncologist who provides compassionate and evidence-based care for individuals diagnosed with solid organ malignancies. Specialising in medical oncology, Dr Dearden focuses primarily on the non-surgical management of urological cancers, including bladder, kidney, prostate, and penile carcinomas, alongside skin cancers such as melanoma. She is committed to delivering highly personalised treatment strategies that prioritise both clinical effectiveness and patient wellbeing, ensuring clear communication and reassuring guidance at every stage of the cancer pathway.

In her clinical practice, Dr Dearden utilises advanced systemic anti-cancer therapies tailored to the specific biological characteristics of each tumour. Her therapeutic expertise covers conventional chemotherapy regimens, targeted biological agents, and modern immunotherapies, including immune checkpoint inhibitors. Dr Dearden pays particular attention to managing treatment tolerance and monitoring potential immune-related toxicities, helping patients safely navigate their treatment while maintaining their quality of life.

In addition to her clinical work, Dr Dearden completed higher specialist training in Medical Oncology and pursued dedicated research experience in clinical trial design and execution. She is actively involved in collaborative clinical research, having served as a Principal Investigator for national phase II and phase III clinical trials investigating novel immunotherapy combinations in genitourinary cancers. She maintains active professional memberships with national oncology research networks, contributing to multi-centre studies focused on improving treatment safety and outcomes for older adults receiving anti-cancer therapies.